Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

NSE/NURECA stock hub

NSE/NURECA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/NURECAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.8B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/NURECA

In the news

Latest news · NSE/NURECA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E26.6

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC2.2

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/NURECA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

INR

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	171
Employees Change	33%
Employees Change Percent	23.91
Enterprise value	INR 2.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Devices
Isin	INE0DSF01015
Last refreshed	2026-05-10
Market cap	INR 2.8B
Price	INR 294
Price currency	INR
Rev Per Employee	8,380,000x
Sector	Healthcare
Sic	3845
Symbol	nse/NURECA
Website	https://www.nureca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.8%
EV Earnings	25.97x
EV/EBIT	54.49x
EV/EBITDA	38.73x
EV/Sales	1.93x
P/B ratio	1.41x
P/E ratio	26.61x
P/S ratio	1.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.54%
EBITDA Margin	4.19%
Gross margin	36.97%
Gross Profit	INR 529.7M
Gross Profit Growth	53.55%
Gross Profit Growth Q	44.96%
Gross Profit Growth3 Y	6.61%
Gross Profit Growth5 Y	8.86%
Net Income	INR 106.4M
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Net Income Growth5 Y	10.72%
Pretax Margin	8.75%
Profit Margin	7.43%
Profit Per Employee	INR 622,339
Profitable Years	1
Roa5y	7.92
Roe5y	14.4
ROIC	2.2
Roic5y	16.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	26.18%
Cagr3y	-4.45%
Cagr5y	-27.48%
EPS Growth Quarters	2
EPS Growth Years	2
EPS Growth5 Y	3.82
Revenue Growth	51.01x
Revenue Growth Q	49.8x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	3x
Revenue Growth5 Y	7.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 87.4M
Debt	INR 53.9M
Debt EBITDA	INR 0.76
Debt Equity	INR 0.03
Equity	INR 2B
Interest Coverage	6.53
Net Cash	INR 33.5M
Net Cash By Market Cap	INR 1.2
Net Cash Growth	-85.43%
Net Debt EBITDA	INR -0.56
Net Debt Equity	INR -0.02
Tangible Book Value	INR 2B
Tangible Book Value Per Share	INR 170
WACC	7.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.4%
Dividend per share	INR 0
Last Dividend	INR 3

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	26.16%
200-day SMA	266.1
3Y total return	-12.77%
50-day SMA	261.3
50-day SMA vs 200-day SMA	50under200
5Y total return	-79.93%
All Time High	2,315
All Time High Change	-87.3%
All Time High Date	2021-10-08
All Time Low	203.6
All Time Low Change	44.39%
All Time Low Date	2025-04-07
ATR	13.7
Beta	0.66
Beta1y	1.25
Beta2y	0.74
Ch YTD	-4.53
High	300
High52	343
High52 Date	2025-10-20
High52ch	-14.29%
Low	284.8
Low52	204
Low52 Date	2026-03-30
Low52ch	44.12%
Ma50ch	12.52%
Price vs 200-day SMA	10.47%
RSI	68.7
RSI Monthly	49.11
RSI Weekly	55.15
Sharpe ratio	0.69x
Sortino ratio	1.28
Total Return	3.4%
Tr YTD	-4.53
Tr1m	23.24%
Tr1w	12.97%
Tr3m	6.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 50.7M
Operating Income Growth5 Y	-11.46
Operating margin	3.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,748,248%
Shares Insiders	70.56%
Shares Out	9,541,920
Shares Qo Q	-17.3%
Shares Yo Y	-3.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	12,419.95x
Bv Per Share	172.1
Ch1m	23.24
Ch1w	12.97
Ch1y	26.16
Ch3m	6.14
Ch3y	-12.77
Ch5y	-80
Ch6m	3.25
Change	1.4%
Change From Open	1.03
Close	290
Days Gap	0.36
Depreciation Amortization	9,265,000
Dollar Volume	3,807,006
Earnings Date	2026-05-07
EBIT	INR 50.7M
EBITDA	INR 60M
EPS	INR 11.02
F Score	2
Fiscal Year End	March
Founded	2,016
Graham Number	206.54676
Graham Upside	-29.75
Income Tax	INR 19M
Is Primary Listing	1
Last Earnings Date	2026-01-17
Last Report Date	2025-12-31
Lynch Fair Value	INR 118
Lynch Upside	-59.81
Ma150	273
Ma150ch	7.68%
Ma20	267.8
Ma20ch	9.8%
Open	291
Position In Range	60.53
Price Date	2026-05-08
Price EBITDA	INR 46.63
Ptbv Ratio	1.42
Relative Volume	1.04x
Revenue	1,432,980,000x
Tax By Revenue	1.33x
Tax Rate	15.16%
Tr6m	3.25%
Volume	12,949

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/NURECA pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/NURECA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/NURECA?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+70.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-3.4%

Negative means the company is buying back shares.

Technical

NSE/NURECA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.7

Neutral momentum band

Price vs 200-day MA

+10.5%

50/200-day relationship not available

Beta (5Y)

0.66

Less volatile than the market

Sharpe ratio

0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/NURECA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/NURECA stock rating?

nse/NURECA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/NURECA analysis?

The full report lives at /stocks/nse/NURECA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/NURECA?

The latest report frames nse/NURECA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/NURECA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.